Research Article
All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes
Table 1
Descriptive characteristics of women at baseline stratified by glycaemic status (NFG = normal fasting glucose, IFG = impaired fasting glucose, and diabetes). Data are shown as median (interquartile range) or n (%).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
indicates missing data: fasting plasma glucose and blood pressure ; body fat and lean mass ; percentage body fat ; waist and hip circumference, waist-to-hip ratio, and waist-to-height ratio ; serum triglycerides ; serum HDL cholesterol ; serum LDL cholesterol ; metabolic syndrome . ¥ indicates that hypertensive (y/n) was considered if the participant had a systolic blood pressure > 140 mmHg and/or a diastolic pressure > 90 mmHg and/or use of antihypertensive medication. † indicates metabolic syndrome excluding fasting plasma glucose. # indicates unadjusted mortality. |